Allogene Therapeutics (NASDAQ:ALLO) Shares Up 13.1% After Analyst Upgrade

Allogene Therapeutics, Inc. (NASDAQ: ALLO - Get Free Report) shares shot up 13.1% during mid-day trading on Thursday after JPMorgan Chase and Co. upgraded the stock from an underweight rating to a neutral rating. The company traded as high as $2.45 and last traded at $2.4550. 4,605,023 shares were traded during trading, a decline of 45%